We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Early Cardiac Computed Tomography (CT) In Patients Admitted With Acute Chest Pain (EXACCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00767065
Recruitment Status : Unknown
Verified September 2008 by Chelsea and Westminster NHS Foundation Trust.
Recruitment status was:  Not yet recruiting
First Posted : October 6, 2008
Last Update Posted : October 6, 2008
Royal Brompton & Harefield NHS Foundation Trust
British Heart Foundation
Information provided by:
Chelsea and Westminster NHS Foundation Trust

Brief Summary:
This is a randomised trial comparing early Cardiac Computed Tomography (CCT) to current standard practice for diagnosis of acute chest pain in patients at low to intermediate risk of having coronary artery disease (CAD), in a UK setting. We hypothesise that early CCT can reduce length of admission, reduce NHS costs and improve quality of life whilst being at least as safe as standard practice.

Condition or disease Intervention/treatment
Acute Chest Pain Radiation: Cardiac Computed Tomography Other: Standard care

Detailed Description:

Coronary Artery Disease (CAD) kills more people in the UK than any other condition, and causes symptoms of angina (chest pain) in many more. Acute chest pain accounts for approximately 600,000 NHS admissions per annum, but this includes many other types of chest pain not due to heart problems. Examination, blood tests and an electrocardiogram (ECG) are used to try and decide the cause of chest pain.

Many patients have a low risk of CAD and can be discharged without further investigation. Others are at high risk of CAD and must have further tests such as invasive coronary angiography. Unfortunately in many patients the initial tests are equivocal and they are felt to have an intermediate probability of CAD. Investigation of symptoms in this group may take place in the in-patient setting, warranting a hospital stay of several days, or alternatively some investigations may be performed as an out-patient with subsequent time spent on waiting lists. This results in extensive use of NHS resources and anxiety for the patients whilst awaiting diagnosis, often needlessly as approximately half of patients admitted with acute chest pain are eventually discharged without a cardiac cause found.

The new technique of cardiac computed tomography (CCT) offers rapid non-invasive diagnosis of CAD. If disease is detected further investigations can be planned; when excluded, patients may be safely discharged. Detection of clinically insignificant disease will initiate primary preventative strategies but excludes CAD as the cause of acute symptoms. We will randomise 250 patients presenting to Chelsea and Westminster Hospital with acute chest pain who have intermediate likelihood of CAD to early CCT or current standard practice. We hypothesise that, when compared to standard practice, early CCT will reduce admission length, reduce NHS and other costs and improve quality of life without an increase in adverse events.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 250 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: The Role of Early X-Ray Cardiac Computed Tomography in Patients Admitted With Acute Chest Pain
Study Start Date : January 2009
Estimated Primary Completion Date : December 2010
Estimated Study Completion Date : December 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: Cardiac Computed Tomography (CCT)
Patients randomised to the CCT arm will undergo 128-channel cardiac computed tomography with delayed acquisition. CCT will be available Monday to Friday from 9am until 5pm. Patients will be entered into the study provided CCT can be undertaken within 24 hours of troponin result. Therefore, the only period during which a patient will be ineligible for inclusion will be between 5pm on a Friday and 9am the following Sunday. Studies will be reported at CWH by one of 2 experienced radiologists trained in CCT and results passed to the referring team on the same day.
Radiation: Cardiac Computed Tomography
Patients randomised to the CCT arm will undergo 128-channel cardiac computed tomography with delayed acquisition. Patients will receive beta-blockade if necessary prior to the scan to achieve a heart rate of less than 70/min. An unenhanced scan will be performed in all patients to assess coronary artery calcium score. Patients will then undergo contrast enhanced CCT. After a bolus tracking acquisition, injection of 120mls iodinated contrast at 5ml/s will be followed by 40ml normal saline/contrast (in 50:50 proportion), also at 5ml/s. Imaging will be performed with a gated cardiac CT protocol. Where possible (stable rhythm and heart rate <70bpm) a low dose technique will be utilised. When not possible a retrospective gating method will be employed. In the latter case the ECG will be used to assign the images to their respective phases of the cardiac cycle. 10 minutes after contrast injection, a second prospectively gated scan will be acquired to assess myocardial enhancement patterns.
Active Comparator: Standard Care Arm
Patients randomised to the standard care arm will undergo further care as dictated by the responsible clinician. Except for CCT, all standard investigations will be available to the responsible clinician and may be used at their discretion. CCT does not form part of current in-patient management at our hospital.
Other: Standard care
Further investigations as decided by the patient's clinical team, according to best normal practice. These may include some or all of: further blood tests, exercise stress testing and myocardial perfusion scintigraphy. These may be conducted either during the initial hospital admission, or subsequently as an outpatient.

Primary Outcome Measures :
  1. Length of hospital admission [ Time Frame: At the end of initial hospital admission ]

Secondary Outcome Measures :
  1. NHS costs and cost-effectiveness over a one-year period [ Time Frame: One year ]
  2. Patient quality of life at 1, 6 and 12 months after admission [ Time Frame: 1 year ]
  3. Patient anxiety about symptoms 1, 6 and 12 months after admission [ Time Frame: 1 year ]
  4. The incidence of major adverse cardiovascular events (MACE) over a one year period. [ Time Frame: 1 year ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   40 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Admission with suspected cardiac chest pain
  2. >40 years of age
  3. EITHER Low likelihood of CAD according to DFC and troponin>0.03 but <3 OR Intermediate likelihood of CAD according to DFC
  4. Written informed consent

Exclusion Criteria:

  1. ECG consistent with acute myocardial infarction (ST elevation, new left bundle branch block)
  2. Ongoing chest pain with dynamic ECG changes
  3. Haemodynamic or respiratory instability
  4. Serum troponin ≥3
  5. Previous percutaneous coronary intervention or coronary artery bypass grafting
  6. Admission to hospital between 5pm Friday and 9am Sunday
  7. Contraindication to negative chronotropic agents
  8. Maximum heart rate >70bpm (including after pharmacologic treatment)
  9. Renal dysfunction (Creat>150 micromol/l)
  10. Pregnancy or childbearing potential
  11. Allergy or previous intolerance of iodinated contrast

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00767065

Contact: Simon Padley, MB BS BSc FRCP FRCR (0044) 020 8746 8000 s.padley@ic.ac.uk
Contact: Jim Stirrup, MB BS BSc MRCP (0044) 020 7352 8121 j.stirrup@rbht.nhs.uk

United Kingdom
Chelsea and Westminster Hospital Not yet recruiting
London, United Kingdom, SW10 9NH
Sponsors and Collaborators
Chelsea and Westminster NHS Foundation Trust
Royal Brompton & Harefield NHS Foundation Trust
British Heart Foundation
Principal Investigator: Simon Padley, MB BS BSc FRCP FRCR Chelsea and Westminster NHS Foundation Trust

Responsible Party: Dr Simon Padley, Chelsea and Westminster NHS Foundation Trust
ClinicalTrials.gov Identifier: NCT00767065     History of Changes
Other Study ID Numbers: CWRT/SP2008/1
First Posted: October 6, 2008    Key Record Dates
Last Update Posted: October 6, 2008
Last Verified: September 2008

Additional relevant MeSH terms:
Chest Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms